2021
DOI: 10.1016/j.cjco.2020.09.001
|View full text |Cite|
|
Sign up to set email alerts
|

A Literature Review of Cannabis and Myocardial Infarction—What Clinicians May Not Be Aware Of

Abstract: Increasing legalization and expanding medicinal use have led to a significant rise in global cannabis consumption. With this development, we have seen a growing number of case reports describing adverse cardiovascular events, specifically, cannabis-induced myocardial infarction (MI). However, there are considerable knowledge gaps on this topic among health care providers. This review aims to provide an up-to-date review of the current literature, as well as practical recommendations for clinicians. We also foc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(19 citation statements)
references
References 76 publications
(61 reference statements)
1
17
0
Order By: Relevance
“…This effect was abolished following exposure to a CB2 receptor antagonist. However, smoking cannabis with uncontrolled quantity of cannabinoids may induce adverse effects on the cardiovascular system [ 49 ]. These findings provide information about the potential therapeutic values of using cannabinoids for the treatments of atherosclerosis-related diseases.…”
Section: Discussionmentioning
confidence: 99%
“…This effect was abolished following exposure to a CB2 receptor antagonist. However, smoking cannabis with uncontrolled quantity of cannabinoids may induce adverse effects on the cardiovascular system [ 49 ]. These findings provide information about the potential therapeutic values of using cannabinoids for the treatments of atherosclerosis-related diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Multiple case reports have linked marijuana to thrombus formation, leading to acute MI [ 13 ], and the authors quote the publication by Deusch et al [ 91 ] on human platelets in vitro in which CB 1 - and CB 2 -Rs are expressed and THC enhances expression of the platelet fibrinogen receptor (glycoprotein IIb-IIIa) and P-selectin; experiments with CB-R antagonists were not performed in that study. In other studies, THC by itself failed to modify the aggregation of human platelets [ 186 ] and even decreased aggregation of human and rabbit platelets induced by various factors [ 182 ].…”
Section: Thrombus Formation and Coronary Constriction?mentioning
confidence: 99%
“…Their distribution is not controlled and they are easily available as “seemingly innocent, herbal products”. They possess structural and biochemical similarities and exert even more potent and deleterious adverse effects in comparison to THC due to their greater affinity for the CB 1 -R, the CB-R subtype responsible for the psychotropic effects of cannabis (for affinities of THC and other cannabinoids considered in this review, see Figure 1 ) [ 10 , 11 , 12 , 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…51 cases describing cannabis-related MI had been reported in the literature. The first case was described in 2003, since then the number of cases is significantly rising [ 6 ]. K. Chetty and reported in the literature review that the mean age of the patients was 31 years.…”
Section: Discussionmentioning
confidence: 99%